文献速递冠心病

左主干血运重建后再入院的发生率、预测因素及对预后的影响

Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.
PubMed 文献 · J Am Coll Cardiol · 2024-01-01

EXCEL试验随机1,905例左主干冠心病患者至PCI或CABG,分析5年再入院情况。1,882例存活出院者中851例(45.2%)发生再入院,PCI组再入院率48.6%高于CABG组41.8%(P=0.003)。再入院独立预测全因死亡,且PCI组风险高于CABG组(交互P=0.03)。

要点

  • 左主干血运重建后5年再入院率高达45.2%,PCI高于CABG。
  • PCI是全因再入院的独立预测因素(校正HR 1.22)。
  • 再入院与全因死亡增加相关,PCI后风险高于CABG后。

核心结论

  • 左主干冠心病血运重建后5年再入院常见,PCI较CABG更频繁。
  • 再入院与全因死亡风险增加独立相关,且PCI后风险高于CABG后。

研究设计与样本

  • EXCEL试验事后分析,1,905例左主干冠心病患者随机接受PCI或CABG。
  • 采用多变量Anderson-Gill模型和联合脆弱模型分析再入院累积发生率,并考虑复发事件和死亡竞争风险。
  • 采用时间调整的Cox比例风险模型评估再入院对5年随访内后续死亡的影响。

主要发现

  • 5年内1,882例存活出院者中851例(45.2%)发生再入院,共1,868次再入院(人均2.2±1.9次,范围1-16次)。
  • 再入院原因约一半为心血管原因(927次,49.6%),一半为非心血管原因(941次,50.4%)。
  • PCI组463/942例(48.6%)发生一次以上再入院,CABG组388/940例(41.8%)(P=0.003)。
  • 多变量校正后PCI仍为再入院的独立预测因素(校正HR 1.22;95%CI 1.10-1.35;P<0.0001),女性、合并症和冠心病范围亦为预测因素。
  • 再入院与后续全因死亡独立相关,交互检验示PCI后风险高于CABG后(校正HR 5.72;95%CI 3.42-9.55 vs 校正HR 2.72;95%CI 1.64-4.88;Pint=0.03)。

临床怎么用

  • 左主干血运重建后应重视再入院风险评估与随访管理,尤其PCI患者。
  • 再入院事件可作为后续死亡风险增高的警示信号,需加强干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The frequency of and relationship between hospital readmissions and outcomes after revascularization for left main coronary artery disease (LMCAD) are unknown. OBJECTIVES: The purpose of this study was to study the incidence, predictors, and clinical impact of readmissions following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for LMCAD. METHODS: In the EXCEL (XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial, 1,905 patients with LMCAD were randomized to PCI vs CABG. The cumulative incidence of readmissions was analyzed with multivariable Anderson-Gill and joint frailty models to account for recurrent events and the competing risk of death. The impact of readmission on subsequent mortality within 5-year follow-up was determined in a time-adjusted Cox proportional hazards model. RESULTS: Within 5 years, 1,868 readmissions occurred in 851 of 1,882 (45.2%) hospital survivors (2.2 ± 1.9 per patient with readmission[s], range 1-16), approximately one-half for cardiovascular causes and one-half for noncardiovascular causes (927 [49.6%] and 941 [50.4%], respectively). One or more readmissions occurred in 463 of 942 (48.6%) PCI patients vs 388 of 940 (41.8%) CABG patients (P = 0.003). After multivariable adjustment, PCI remained an independent predictor of readmission (adjusted HR: 1.22; 95% CI: 1.10-1.35; P < 0.0001), along with female sex, comorbidities, and the extent of CAD. Readmission was independently associated with subsequent all-cause death, with interaction testing indicating a higher risk after PCI than CABG (adjusted HR: 5.72; 95% CI: 3.42-9.55 vs adjusted HR: 2.72; 95% CI: 1.64-4.88, respectively; Pint = 0.03). CONCLUSIONS: In the EXCEL trial, readmissions during 5-year follow-up after revascularization for LMCAD were common and more frequent after PCI than CABG. Readmissions were associated with an increased risk of all-cause death, more so after PCI than with CABG.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Kosmidou I, Shahim B, Dressler O, et al. Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease. J Am Coll Cardiol. 2024. PMID: 38479955. doi:10.1016/j.jacc.2024.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。